Ovintiv Inc.: Form 10-Q for the period ended Sep 30, 2024
Filed with the SEC on Nov 7, 2024 and accepted by EDGAR at Nov 7, 2024, 17:09 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-07-01 to 2024-09-30 | $2.18bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2024-01-01 to 2024-09-30 | $6.76bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Operating income | 3 months2024-07-01 to 2024-09-30 | $527.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2024-01-01 to 2024-09-30 | $1.58bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2024-07-01 to 2024-09-30 | $103.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2024-01-01 to 2024-09-30 | $306.0m | us-gaap:InterestExpense |
| Income tax | 3 months2024-07-01 to 2024-09-30 | $51.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2024-01-01 to 2024-09-30 | $267.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-07-01 to 2024-09-30 | $507.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2024-01-01 to 2024-09-30 | $1.19bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-07-01 to 2024-09-30 | $1.92 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2024-01-01 to 2024-09-30 | $4.41 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-07-01 to 2024-09-30 | $1.93 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2024-01-01 to 2024-09-30 | $4.45 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-07-01 to 2024-09-30 | 264,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2024-01-01 to 2024-09-30 | 268,700,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2024-07-01 to 2024-09-30 | $1.02bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Operating cash flow | 9 months2024-01-01 to 2024-09-30 | $2.70bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2024-07-01 to 2024-09-30 | $538.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Capital expenditure | 9 months2024-01-01 to 2024-09-30 | $1.75bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2024-07-01 to 2024-09-30 | $78.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Dividends paid | 9 months2024-01-01 to 2024-09-30 | $238.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2024-07-01 to 2024-09-30 | $163.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Share repurchases | 9 months2024-01-01 to 2024-09-30 | $597.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-09-30 | $9.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-09-30 | $1.51bn | us-gaap:AssetsCurrent |
| Total assets | At period end2024-09-30 | $19.86bn | us-gaap:Assets |
| Current liabilities | At period end2024-09-30 | $2.89bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-09-30 | $9.20bn | us-gaap:Liabilities |
| Long-term debt | At period end2024-09-30 | $4.85bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2024-09-30 | $1.02bn | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2024-09-30 | $10.65bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-24-123514. Last ingested by Listed: Nov 3, 2026, 21:35 ET. Listed shows no prices and gives no investment advice.